Exelixis
EXEL
#1759
Rank
S$15.25 B
Marketcap
S$56.68
Share price
-0.25%
Change (1 day)
14.74%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company